Tohme Scarlett, Newman Joshua S, Gasparis Christopher, Manetta Frank
Department of Cardiovascular and Thoracic Surgery, North Shore University Hospital, Northwell Health, Manhasset, New York.
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.
Int J Angiol. 2022 Aug 20;31(3):179-187. doi: 10.1055/s-0042-1755573. eCollection 2022 Sep.
Pulmonary embolism is the third most common cardiovascular syndrome with an estimated up to 25% of patients presenting with sudden death. For those who survive, a mainstay of management for patients with hemodynamic stability is anticoagulation; however, recommendations and options are rapidly changing for patients with submassive or massive pulmonary embolism with hemodynamic instability. Catheter-based and surgical approaches offer efficacious management options for unstable patients or patients with contraindications to anticoagulation; however, both approaches have inherent benefits and risk. This article seeks to offer a brief review on the recommendations and options for management of pulmonary embolism from both surgical and catheter-based perspectives.
肺栓塞是第三常见的心血管综合征,估计高达25%的患者会猝死。对于幸存者而言,血流动力学稳定的患者的主要治疗方法是抗凝;然而,对于有血流动力学不稳定的次大面积或大面积肺栓塞患者,治疗建议和选择正在迅速变化。基于导管和手术的方法为不稳定患者或对抗凝有禁忌证的患者提供了有效的治疗选择;然而,这两种方法都有其固有的益处和风险。本文旨在从手术和基于导管的角度对肺栓塞的治疗建议和选择进行简要综述。